Get the Stockscreener App
49.32
0.06%
-0.03
After Hours:
49.32
Qiagen Nv stock is traded at $49.32, with a volume of 654.83K.
It is down -0.06% in the last 24 hours and up +9.43% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
See More
Previous Close:
$49.35
Open:
$49.5
24h Volume:
654.83K
Relative Volume:
0.55
Market Cap:
$10.70B
Revenue:
$2.04B
Net Income/Loss:
$373.39M
P/E Ratio:
29.08
EPS:
1.6961
Net Cash Flow:
$495.96M
1W Performance:
+2.18%
1M Performance:
+9.43%
6M Performance:
+14.54%
1Y Performance:
+15.26%
1-Day Range:
$49.06
$49.53
1-Week Range:
$48.15
$49.59
52-Week Range:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
49.32 | 10.70B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
572.50 | 215.96B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
223.01 | 157.33B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
640.85 | 51.09B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
148.03 | 41.80B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.52 | 37.38B | 15.70B | 1.24B | 2.01B | 6.9036 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-04-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-06-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
How Qiagen N.V. Common Shares stock trades after rate cutsJuly 2025 Drop Watch & Daily Stock Trend Reports - newser.com
Is Qiagen N.V. stock a safe haven asset2025 Investor Takeaways & Daily Price Action Insights - newser.com
Using portfolio simulators with Qiagen N.V. included2025 Short Interest & Community Consensus Picks - newser.com
Can Qiagen N.V. stock sustain free cash flow growthMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
What valuation ratios show for Qiagen N.V. Common Shares stock2025 Geopolitical Influence & Consistent Profit Trade Alerts - newser.com
Will Qiagen N.V. (QIA) stock keep high P E multiplesMarket Risk Summary & Entry Point Confirmation Alerts - newser.com
What to expect from Qiagen N.V. in the next 30 days2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com
Will breakout in Qiagen N.V. lead to full recoveryJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
Can Qiagen N.V. stock hit record highs againQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Regression analysis insights on Qiagen N.V. performanceInsider Selling & Free Verified High Yield Trade Plans - newser.com
Qiagen (NYSE:QGEN): Assessing Valuation After Recent Share Price Rebound - simplywall.st
How to integrate Qiagen N.V. into portfolio analysis toolsTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
Is Qiagen N.V. (QIA) stock overpriced at current multiplesGap Up & Verified Entry Point Signals - newser.com
Published on: 2025-10-24 20:25:15 - newser.com
Bank of America Discloses Significant Indirect Holdings in QIAGEN - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Sector Gamma AS Trims Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):